CFTR and COVID-19: For example, it is known that pathogenic heterozygous variants in the CFTR gene lead to an increased risk of chronic pancreatitis, atypical mycobacterial infections, and bronchiectasis [40], and in the future some heterozygous variants in AR genes may be shown to confer an increased risk in case of COVID-19 severity.